|Moved from Ca to GA, ADAP waiting list
Mar 26, 2012
So I recently moved from CA to GA, I was enrolled in ADAP in CA and taking Complera. And now I'm trying to enroll here in GA, but I come to find out that there in a HUGH waiting list here, that I will be put on. I talked to a case manager, and she did mention that because I'm currently on treatment, that there might be a possibility to get my meds directly the pharmaceutical companies. So I want to know how what are the possibilities of that happening, and if not, I am worried that I will be put on this waiting list and have to stop taking my meds (complera). Also, would I build a resistance if I am forced to stop taking them?
| Response from Dr. McGowan
I am sorry to hear about your difficulties.
This is a huge problem with the way our health care system is set up, it is run state by state (which will not change by the way with the implementation of the Affordable Care Act).
The number for the Gilead Patient Assistance Program is: 1 800 226 -2056.(http://www.gilead.com/us_advancing_access).
I wish you succcess.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- What Are The Chances Of Getting AIDS From Sucking Breast?
- Is Sinus Infection An Early Sign Of HIV?
- Is Tingling In Feet A Symptom Of Acute HIV Infection?
- Blowjob From A Prostitute How Long Does It Take To Test Positive For HIV
- Black Spots After Anal Sex Without Condom Does It Mean I Have HIV
- Burning Urethra After Touching Dried Semen Worried I Have HIV
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.